Lipid DisorderNCT00277121
Genetic Origin of Lipid Disorders
An observational study of Lipid Disorder, run by University of Oslo at 1 site in Norway.
Trial summary
Several lipid disorders are without known genetic origin. The scope of this project is to sequence genes superior involved in lipid and carbohydrate metabolism in patients with severe lipid disorders. Read more about this study
- Who is it for?
- Ages 18 to 54 yearsHealthy volunteers can take part
- Conditions the study is for
- Lipid Disorder
- How many people
- Not given
- Where
- 1 siteNorway
- Study dates
- Jan 2006to not given
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 54 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- proven written informed consent prior to recruitment
- male or female
- 18-55 years old
- patients with severe lipid disorders
- fasting plasma cholesterol, triglyceride or glucose, blood pressure or waist circumference/BMI out of normal range
Who cannot join
- -
Trial locations and contacts
1 site in 1 country.
About this study
Several lipid disorders are without known genetic origin. The scope of this project is to sequence genes superior involved in lipid and carbohydrate metabolism in patients with severe lipid disorders. The resulting mutations will be tested in suitable in vitro systems to detect their part in development of the specific disease.
Read the detailed description
See "brief summary" above.
- Conditions
- Lipid Disorder
- Keywords
- Lipid disorder, Gene mutation
- Medical subject headings
- Lipid Metabolism Disorders
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Jan 2006 (estimated)
- Study startJan 2006
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Lipid DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Other
Sponsor and investigators
- Lead sponsor
- University of Oslo
- Sponsor type
- University, hospital or other
- Collaborators
- Lipid Clinic, The National Hospital, Oslo, Norway, Research Institute of Internal Medicine, The National Hospital, Oslo, Norway, Ullevaal University Hospital, Norwegian Institute of Public Health, Hormone Laboratory, Aker University Hospital, Oslo, Norway, CIGENE, Agricultural University of Norway, Aas, Norway
- Investigators
- Hilde I Nebb, PhD, Study chair, Department of Nutrition, University of OsloKarianne Solaas, PhD, Principal investigator, Department of Nutrition, University of OsloMonica H Carlsen, Principal investigator, Department of Nutrition, University of OsloLeiv Ose, Dr med, Principal investigator, Lipid Clinic, The National HospitalMarit S Nenseter, PhD, Principal investigator, Research Institute of Internal Medicine, The National HospitalKirsten Holven, PhD, Principal investigator, Research Institute of Internal Medicine, The National HospitalBente Halvorsen, PhD, Principal investigator, Research Institute of Internal Medicine, The National HospitalSerena Tonstad, Dr med, Principal investigator, Department of Preventive Medicine, Ullevål university hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00277121
- Sponsor's protocol ID
- S-03150 (REK)
- Other IDs
- 02/4746 (SHdir), 10163 (NSD)
- Status last verified
- Jan 2006
- First submitted
- 12 Jan 2006
- Last updated
- 13 Jan 2006
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Jan 2006. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Genetic Origin of Lipid Disorders
- ClinicalTrials.gov ID
- NCT00277121
- Acronym / sponsor ID
- S-03150 (REK)
- Conditions
- Lipid Disorder
- Keywords
- Lipid disorder, Gene mutation
- Study type
- Observational
- Recruitment status
- Unknown status
- Lead sponsor
- University of OsloUniversity, hospital or other
- Collaborators
- Lipid Clinic, The National Hospital, Oslo, Norway, Research Institute of Internal Medicine, The National Hospital, Oslo, Norway, Ullevaal University Hospital, Norwegian Institute of Public Health, Hormone Laboratory, Aker University Hospital, Oslo, Norway, CIGENE, Agricultural University of Norway, Aas, Norway
- Study start
- Jan 2006
- First posted
- 13 Jan 2006 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Several lipid disorders are without known genetic origin. The scope of this project is to sequence genes superior involved in lipid and carbohydrate metabolism in patients with severe lipid disorders. The resulting mutations will be tested in suitable in vitro systems to detect their part in development of the specific disease.
Detailed description
See "brief summary" above.
Study design
- Observational model
- Case-control
- Time perspective
- Other
Who may qualify
- Ages
- 18 to 54 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- proven written informed consent prior to recruitment
- male or female
- 18-55 years old
- patients with severe lipid disorders
- fasting plasma cholesterol, triglyceride or glucose, blood pressure or waist circumference/BMI out of normal range
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Jan 2006.
Related trials for Lipid Disorder
Not yet recruiting
Plasma Lipids-Dependent Vitamin E Metabolism During Dynamic Hyperlipidemia
Lipid Metabolism Disorders
Not yet recruitingPhase 2
Effects of Meal Macronutrients on Postprandial Lipids
Nephrotic Syndrome, Lipodystrophy
Active, not recruitingObservational study
A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti
Hypertension, Diabetes
Active, not recruiting
Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT)
Cardiovascular Diseases, Hypertension
RecruitingObservational study
Longitudinal Study of Ultra-rare Inherited Metabolic and Degenerative Neurological Diseases.
Inherited Disease, Rare Diseases
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Hilde I Nebb, PhD study chair
Department of Nutrition, University of Oslo
Karianne Solaas, PhD principal investigator
Department of Nutrition, University of Oslo
Monica H Carlsen principal investigator
Department of Nutrition, University of Oslo
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Lipid Disorder, run by University of Oslo at 1 site in Norway.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 13 Jan 2006. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Hilde Irene Nebb, PhD (+47-22851510, h.i.nebb@medisin.uio.no), or a site near the patient. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jan 2006.